Pretesh R. Patel

Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysis.

INTRODUCTION Active surveillance (AS) allows men with favorable-risk prostate cancer (PC) to avoid or delay the toxicity of upfront treatment. However, whether these patients are at higher risk of subsequent treatment intensification with androgen deprivation therapy (ADT) is unknown. Herein, we examine real-world burd...